No Data
No Data
Gene Therapy Developers Rise on Comments From FDA's Makary
$BEAM Stock Is up 9% Today. Here's What We See in Our Data.
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Beam Therapeutics Inc.'s (NASDAQ:BEAM) Recent 11% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
Cathie Wood's ARK ETF Focuses on Beam Therapeutics, Coinbase Stock
FDA Staff Cuts Are Already Impacting Regulatory Work, Biotech Leaders Warn